1. Market Research
  2. > Therapy
16 reports for Salicylic Acid (page 1)

Purchase Reports From Reputable Market Research Publishers

Pediatric Drugs Industry Forecasts - China Focus

  • $ 1800
  • September 2020
  • 118 pages

; third, antipyretic drugs including Paracetamol, Ketoprofen, Aspirin and etc.

  • Analgesic
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy
  • China

Pediatric Drugs Markets in China

  • $ 4000
  • September 2020
  • 228 pages

; third, antipyretic drugs including Paracetamol, Ketoprofen, Aspirin and etc.

  • Analgesic
  • Anti-Infective
  • Respiratory Treatment
  • Salicylic Acid
  • China

Allergy Drugs Markets in China

  • $ 4000
  • May 2020
  • 207 pages

Furthermore HNPOLY is good at R& D and production of micro-pellets for drugs and natural extracts, HNPOLY can provide the products, such as Diclofenac Sodium Sustained-release Micro-pellet, Aspirin and Dipyridamole Sustaind-release capsule, Fenofibrate sustained-release pellets and capsu

  • Allergy Drug
  • Pharmaceutical
  • Respiratory Treatment
  • Salicylic Acid
  • China

GlaxoSmithKline Plc in Consumer Health (World)

  • $ 524
  • April 2017
  • 38 pages

TOP ANALGESICS BRANDS VALUE SALES 2011/ 2016 AND CAGR 2011-2016 Top Analgesics Brands Value Sales 2011/ 2016 and CAGR 2011-2016 ##% ##% ##, ##. ## ##. ## ##. ## Advil Bayer Aspirin Voltaren Panadol Tylenol Nurofen Aleve Salonpas Motrin Doliprane CAGR2011- 2016 USDmillionrsp 2011 2016 % CAGR

  • OTC
  • Respiratory Treatment
  • Salicylic Acid
  • GlaxoSmithKline plc
  • Novartis AG

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017]

  • $ 1112
  • April 2017
  • 1 pages

- At AAAAI 2017, Teva presented data showing that patients with inadequately controlled asthma and aspirin sensitivity received significant improvement in symptoms with reslizumab therapy, but what is the prevalence of aspirin sensitivity and how will the data influence prescribing

  • Asthma
  • Monoclonal Antibody
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 90 pages

Risk factors include asthma, aspirin sensitivity, cystic fibrosis, Churg-strauss syndrome and allergic fungal sinusitis.

  • Monoclonal Antibody
  • Respiratory Disease
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H1 2020

  • $ 2000
  • February 2020
  • 107 pages

Risk factors include asthma, aspirin sensitivity, cystic fibrosis, Churg-strauss syndrome and allergic fungal sinusitis.

  • Monoclonal Antibody
  • Respiratory Disease
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy

Conjunctivitis Global Clinical Trials Review, H1, 2020

  • $ 2500
  • June 2020
  • 433 pages

Aspirin in Acute Stage of Kawasaki Disease Multi-center Prospective Randomized Control Trail of High Dose Aspirin in Acute Stage of Kawasaki Disease GDCT## NCT##, Ophthalmology Angioedema, Conjunctivitis, Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Completed Pha

  • Clinical Trial
  • Ophthalmic Solution
  • Pharmaceutical
  • Respiratory Treatment
  • Salicylic Acid

Bronchospasm Global Clinical Trials Review, H2, 2018

  • $ 2500
  • December 2018
  • 56 pages

Aspirin Induced Bronchospasm in Patients with Aspirin Exacerbated Respiratory Disease (AERD) Undergoing Aspirin Desentization Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization GDCT## NCT##, IRB ##-##; Q##s Respiratory Bronch

  • Clinical Trial
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy
  • Cipla Ltd

Allergic Asthma Global Clinical Trials Review, H2, 2019

  • $ 2500
  • December 2019
  • 218 pages

Aspirin-exazerbated Respiratory Disease (AERD) Effect of Omalizumab in Patients with Aspirin Intolerance, Nasal Polyposis and Allergic Asthma GDCT## EudraCT-2017-##-##, ## Respiratory Allergic Asthma, Asthma, Nasal Polyps (Nasal Polyposis), Rhinosinusitis, Unspecified Respi

  • Asthma
  • Clinical Trial
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy

Chronic Urticaria Or Hives Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020
  • 258 pages

Salicylate ##. ## mg GDCT## NCT##, HL-BPT-## Dermatology Allergic Rhinitis, Chronic Urticaria Or Hives, Pruritus Completed Phase I Interventional bepotastine SR Korea University Anam Hospital Hanlim Pharm Co Ltd ## Apr 2011 ## May 2011 ## ## ## Histamine H## Receptor (HRH##) Antagoni

  • Allergy Drug
  • Clinical Trial
  • Pharmaceutical
  • Respiratory Treatment
  • Salicylic Acid

Chronic Asthma Global Clinical Trials Review, H2, 2018

  • $ 2500
  • December 2018
  • 74 pages

Aspirin Induced Bronchospasm in Patients with Aspirin Exacerbated Respiratory Disease (AERD) Undergoing Aspirin Desentization Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization GDCT## NCT##, IRB ##-##; Q##s Respiratory Bronch

  • Asthma
  • Clinical Trial
  • Respiratory Treatment
  • Salicylic Acid
  • Therapy

Chronic Urticaria Or Hives - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 123 pages

Aspirin-Exacerbated Respiratory Disease: Metaanalysis of Two Phase III Trials". ##-Sep-2018 GlaxoSmithKline plc will provide update on mepolizumabat the European Respiratory Society (ERS) congress in Paris, France.

  • Allergy Drug
  • Dermatological Condition
  • Hospital
  • Pharmaceutical
  • Respiratory Treatment

Chronic Urticaria Or Hives - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 140 pages

Aspirin-Exacerbated Respiratory Disease: Metaanalysis of Two Phase III Trials". ##-Sep-2018 GlaxoSmithKline plc will provide update on mepolizumabat the European Respiratory Society (ERS) congress in Paris, France.

  • Allergy Drug
  • Dermatological Condition
  • Hospital
  • Monoclonal Antibody
  • Respiratory Treatment

The US Market for Rx to OTC Switches, 7th Edition

  • $ 3995
  • February 2015
  • 200 pages

Aspirin is one of the oldest pain remedies and is used to relieve pain and reduce fever.

  • Gastrointestinal Drug
  • OTC
  • Respiratory Treatment
  • Salicylic Acid
  • United States

Generic Drugs Market in Japan 2015-2019

  • $ 2500
  • February 2015
  • 94 pages

Its product portfolio comprises of over ## products, including Acarbose, Aciclovir, Ambroxol, Aspirin, Atenolol, Amlodipine Besilate, Benzbromarone, Cefaclor, and Diclofenac.

  • Anti-Infective
  • Opioid
  • Respiratory Treatment
  • Salicylic Acid
  • Japan


View report >

Healthcare Industry - Company Report, December 2017

  • December 2017
  • 162 pages

Place Yosprala™ (aspirin/ omeprazole delayed-release tablets) into the Special Prior Authorization (PA) Tier of the Anti-Ulcer PBPA category.

  • Anti-Infective
  • Respiratory Treatment
  • Salicylic Acid
  • Targeted Therapy
  • Therapy

Therapy Market in the US November 2001

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on